vs

Side-by-side financial comparison of CORCEPT THERAPEUTICS INC (CORT) and Porch Group, Inc. (PRCH). Click either name above to swap in a different company.

CORCEPT THERAPEUTICS INC is the larger business by last-quarter revenue ($202.1M vs $121.1M, roughly 1.7× Porch Group, Inc.). CORCEPT THERAPEUTICS INC runs the higher net margin — 12.0% vs -3.9%, a 15.9% gap on every dollar of revenue. On growth, Porch Group, Inc. posted the faster year-over-year revenue change (100.0% vs 11.1%). Over the past eight quarters, Porch Group, Inc.'s revenue compounded faster (26.4% CAGR vs 17.3%).

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.

CORT vs PRCH — Head-to-Head

Bigger by revenue
CORT
CORT
1.7× larger
CORT
$202.1M
$121.1M
PRCH
Growing faster (revenue YoY)
PRCH
PRCH
+88.9% gap
PRCH
100.0%
11.1%
CORT
Higher net margin
CORT
CORT
15.9% more per $
CORT
12.0%
-3.9%
PRCH
Faster 2-yr revenue CAGR
PRCH
PRCH
Annualised
PRCH
26.4%
17.3%
CORT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CORT
CORT
PRCH
PRCH
Revenue
$202.1M
$121.1M
Net Profit
$24.3M
$-4.7M
Gross Margin
98.7%
52.7%
Operating Margin
2.2%
34.7%
Net Margin
12.0%
-3.9%
Revenue YoY
11.1%
100.0%
Net Profit YoY
-21.0%
2.0%
EPS (diluted)
$0.20
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORT
CORT
PRCH
PRCH
Q1 26
$121.1M
Q4 25
$202.1M
$112.3M
Q3 25
$207.6M
$115.1M
Q2 25
$194.4M
$107.0M
Q1 25
$157.2M
$84.5M
Q4 24
$181.9M
$75.3M
Q3 24
$182.5M
$77.7M
Q2 24
$163.8M
$75.9M
Net Profit
CORT
CORT
PRCH
PRCH
Q1 26
$-4.7M
Q4 25
$24.3M
$-3.5M
Q3 25
$19.7M
$-10.9M
Q2 25
$35.1M
$2.6M
Q1 25
$20.5M
$8.4M
Q4 24
$30.7M
$30.5M
Q3 24
$47.2M
$14.4M
Q2 24
$35.5M
$-64.3M
Gross Margin
CORT
CORT
PRCH
PRCH
Q1 26
52.7%
Q4 25
98.7%
99.5%
Q3 25
97.8%
75.6%
Q2 25
98.2%
70.9%
Q1 25
98.5%
77.4%
Q4 24
98.4%
Q3 24
98.4%
79.4%
Q2 24
98.5%
22.1%
Operating Margin
CORT
CORT
PRCH
PRCH
Q1 26
34.7%
Q4 25
2.2%
14.7%
Q3 25
4.9%
14.2%
Q2 25
13.7%
4.7%
Q1 25
2.2%
-1.5%
Q4 24
13.9%
33.3%
Q3 24
25.5%
-3.2%
Q2 24
21.7%
-69.2%
Net Margin
CORT
CORT
PRCH
PRCH
Q1 26
-3.9%
Q4 25
12.0%
-3.1%
Q3 25
9.5%
-9.4%
Q2 25
18.1%
2.4%
Q1 25
13.1%
9.9%
Q4 24
16.9%
40.5%
Q3 24
25.9%
18.5%
Q2 24
21.7%
-84.8%
EPS (diluted)
CORT
CORT
PRCH
PRCH
Q1 26
$-0.04
Q4 25
$0.20
$0.00
Q3 25
$0.16
$-0.10
Q2 25
$0.29
$0.00
Q1 25
$0.17
$0.07
Q4 24
$0.25
$0.34
Q3 24
$0.41
$0.12
Q2 24
$0.32
$-0.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORT
CORT
PRCH
PRCH
Cash + ST InvestmentsLiquidity on hand
$372.2M
$68.4M
Total DebtLower is stronger
$391.3M
Stockholders' EquityBook value
$647.8M
$26.3M
Total Assets
$836.7M
$806.6M
Debt / EquityLower = less leverage
14.87×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORT
CORT
PRCH
PRCH
Q1 26
$68.4M
Q4 25
$372.2M
$57.3M
Q3 25
$421.7M
$85.0M
Q2 25
$342.2M
$79.8M
Q1 25
$322.8M
$70.4M
Q4 24
$383.3M
$191.7M
Q3 24
$380.3M
$238.6M
Q2 24
$473.2M
$308.4M
Total Debt
CORT
CORT
PRCH
PRCH
Q1 26
$391.3M
Q4 25
$392.8M
Q3 25
$387.1M
Q2 25
$394.1M
Q1 25
$409.2M
Q4 24
$403.9M
Q3 24
$399.0M
Q2 24
$436.8M
Stockholders' Equity
CORT
CORT
PRCH
PRCH
Q1 26
$26.3M
Q4 25
$647.8M
$-24.6M
Q3 25
$631.9M
$-27.9M
Q2 25
$635.8M
$-29.3M
Q1 25
$683.3M
$-52.4M
Q4 24
$679.6M
$-43.2M
Q3 24
$638.8M
$-77.0M
Q2 24
$596.2M
$-101.9M
Total Assets
CORT
CORT
PRCH
PRCH
Q1 26
$806.6M
Q4 25
$836.7M
$797.4M
Q3 25
$823.6M
$787.7M
Q2 25
$801.7M
$770.7M
Q1 25
$846.5M
$802.3M
Q4 24
$840.6M
$814.0M
Q3 24
$784.3M
$867.3M
Q2 24
$714.6M
$876.1M
Debt / Equity
CORT
CORT
PRCH
PRCH
Q1 26
14.87×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORT
CORT
PRCH
PRCH
Operating Cash FlowLast quarter
$38.4M
Free Cash FlowOCF − Capex
$38.4M
FCF MarginFCF / Revenue
19.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.58×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORT
CORT
PRCH
PRCH
Q1 26
Q4 25
$38.4M
$1.2M
Q3 25
$54.5M
$40.8M
Q2 25
$43.9M
$35.6M
Q1 25
$5.1M
$-11.2M
Q4 24
$59.3M
$-26.6M
Q3 24
$73.8M
$12.4M
Q2 24
$41.2M
$-26.0M
Free Cash Flow
CORT
CORT
PRCH
PRCH
Q1 26
Q4 25
$38.4M
$1.1M
Q3 25
$40.7M
Q2 25
$43.9M
$35.4M
Q1 25
$5.0M
$-11.2M
Q4 24
$59.2M
$-26.8M
Q3 24
$72.2M
$12.2M
Q2 24
$40.8M
$-26.0M
FCF Margin
CORT
CORT
PRCH
PRCH
Q1 26
Q4 25
19.0%
1.0%
Q3 25
35.4%
Q2 25
22.6%
33.0%
Q1 25
3.2%
-13.3%
Q4 24
32.5%
-35.6%
Q3 24
39.5%
15.7%
Q2 24
24.9%
-34.3%
Capex Intensity
CORT
CORT
PRCH
PRCH
Q1 26
Q4 25
0.0%
0.1%
Q3 25
0.0%
0.1%
Q2 25
0.0%
0.2%
Q1 25
0.1%
0.1%
Q4 24
0.1%
0.3%
Q3 24
0.9%
0.3%
Q2 24
0.3%
0.1%
Cash Conversion
CORT
CORT
PRCH
PRCH
Q1 26
Q4 25
1.58×
Q3 25
2.77×
Q2 25
1.25×
13.79×
Q1 25
0.25×
-1.33×
Q4 24
1.93×
-0.87×
Q3 24
1.56×
0.86×
Q2 24
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons